Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Mar;26(3):704-705.
doi: 10.1002/ejhf.3163. Epub 2024 Feb 8.

The gap between real-world and guidelines in the use of sodium-glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry'

Yuqin Zhao  1 , Jun Sun  1 , Cheng Xie  2
Affiliations
Free article
Comment

The gap between real-world and guidelines in the use of sodium-glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry'

Yuqin Zhao et al. Eur J Heart Fail. 2024 Mar.
Free article
No abstract available

PubMed Disclaimer

References

    1. Stolfo D, Lund LH, Benson L, Lindberg F, Ferrannini G, Dahlström U, et al. Real‐world use of sodium‐glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry. Eur J Heart Fail 2023;25:1648–1658. https://doi.org/10.1002/ejhf.2971
    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333
    1. Becher PM, Savarese G, Benson L, Dahlström U, Karlström P, Mol PGM, et al. Eligibility for sotagliflozin in a real‐world heart failure population based on the SOLOIST‐WHF trial enrolment criteria: Data from the Swedish Heart Failure Registry. Eur Heart J Cardiovasc Pharmacother 2023;9:343–352. https://doi.org/10.1093/ehjcvp/pvad012
    1. Becher PM, Schrage B, Ferrannini G, Benson L, Butler J, Carrero JJ, et al. Use of sodium‐glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: Data from the Swedish Heart Failure Registry. Eur J Heart Fail 2021;23:1012–1022. https://doi.org/10.1002/ejhf.2131
    1. Lund LH, Carrero JJ, Farahmand B, Henriksson KM, Jonsson Å, Jernberg T, et al. Association between enrolment in a heart failure quality registry and subsequent mortality – a nationwide cohort study. Eur J Heart Fail 2017;19:1107–1116. https://doi.org/10.1002/ejhf.762

MeSH terms

LinkOut - more resources